Clarification and Corrections to PAR-07-271, Nanoscience and Nanotechnology in Biology and Medicine (R21)

Notice Number: NOT-OD-07-073

Key Dates
Release Date: June 26, 2007

Issued by
National Human Genome Research Institute ( on behalf of the National Institutes of Health (

The National Institutes issued a Funding Opportunity Announcement (FOA) entitled Nanoscience and Nanotechnology in Biology and Medicine (R21) on January 4, 2007 (

The purpose of this Notice is to clarify and make corrections to this FOA.

The type of projects that are acceptable under this FOA. Exploratory/developmental grant support is for new projects only; competing renewal (formerly competing continuation ) applications will not be accepted. The original FOA incorrectly referred to Renewal applications in the Executive Summary. However, renewal applications are not permitted for R21 grants..

Page Limit for Introduction in Resubmission. A resubmission must include an Introduction (one page maximum) addressing the previous peer review critique (Summary Statement). The page limit for the Introduction section for Resubmissions was stated incorrectly in the Executive Summary.

All other aspects of the RFA remain unchanged. The full text of the RFA, which was published on January 4, 2007, can be found at:

This Notice is effective immediately.


We encourage your inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants. Staff Contact information listed under: